In pharmaceutical and medical manufacturing, there’s little room for contamination. Even the smallest airborne particles can challenge the controlled environments that product quality and manufacturing standards depend on.
Controlled environments don't exist in isolation. Weighing, processing, machining, assembly, packaging and the movement of people and materials can all generate or carry airborne particles through pharmaceutical and medical manufacturing facilities.
Weighing, dispensing, blending, granulation and tablet compression can release fine pharmaceutical powders before products ever reach later controlled processes.
Machining, moulding, polishing and assembly can generate fine particles during medical device manufacturing, creating contamination beyond the finished component itself.
Filling, sealing, labelling and packaging introduce further opportunities for particles to enter sensitive production environments or settle on products and packaging.
Every person moving between production areas can carry particles with them. Clothing, footwear and everyday activity can add to the contamination burden across controlled environments.
Raw materials, components, containers and packaging move continuously through production. Every transfer creates another opportunity for contamination to move with them.
Airborne contamination generated outside controlled areas can increase the particle burden around cleanroom environments, adding another challenge to maintaining stable conditions.
In pharmaceutical and medical manufacturing, there is little room for variation. Airborne contamination can affect product quality, controlled environments and compliance, turning an almost invisible problem into very visible consequences.
When quality standards are high, even small contamination events matter. Airborne particles can lead to additional inspections, investigations, rework, rejected products and unnecessary waste.
Cleanroom environments are designed around control. Additional airborne contamination places more pressure on the systems and processes responsible for maintaining it.
Compliance depends on being able to demonstrate control. Airborne contamination can complicate investigations, corrective actions and audit readiness while increasing the effort required to demonstrate process control.
A contamination event doesn't only affect one process. Additional cleaning, quality checks, investigations and production interruptions can quickly consume valuable time and capacity.
Increasing contamination control can come with significant infrastructure costs. Cleanroom expansion and HVAC upgrades require capital, space and ongoing energy, adding long-term cost to already demanding production environments.
Every pharmaceutical product and medical device leaving your facility represents your organisation's commitment to quality. Contamination incidents, rejected products or recalls can can put years of customer confidence at risk.
When quality standards are high, even small contamination events matter. Airborne particles can lead to additional inspections, investigations, rework, rejected products and unnecessary waste.
Cleanroom environments are designed around control. Additional airborne contamination places more pressure on the systems and processes responsible for maintaining it.
Compliance depends on being able to demonstrate control. Airborne contamination can complicate investigations, corrective actions and audit readiness while increasing the effort required to demonstrate process control.
A contamination event doesn't only affect one process. Additional cleaning, quality checks, investigations and production interruptions can quickly consume valuable time and capacity.
Increasing contamination control can come with significant infrastructure costs. Cleanroom expansion and HVAC upgrades require capital, space and ongoing energy, adding long-term cost to already demanding production environments.
Every pharmaceutical product and medical device leaving your facility represents your organisation's commitment to quality. Contamination incidents, rejected products or recalls can can put years of customer confidence at risk.
Airborne contamination doesn't stop at the production line.
Particles travel with people, materials and airflow, moving between production areas, packaging lines and adjacent cleanroom environments.
Protecting pharmaceutical products and medical devices means considering the air around them at every stage.
Air quality monitoring makes the invisible measurable, revealing where airborne contamination is occurring throughout pharmaceutical manufacturing and medical device production.
It helps you:
Once you understand your air quality, you can take targeted action.
Industrial air cleaning continuously removes airborne particles from pharmaceutical and medical device manufacturing environments, reducing the contamination that remains beyond existing controls.
By installing the air cleaning devices, we were able to avoid an expensive investment in a clean room infrastructure. The air cleaning systems are vital for us to maintain the high hygiene standards we set for ourselves.
In pharmaceutical manufacturing, weighing, powder processing, blending and tablet production can generate airborne particles. In medical device manufacturing, machining, moulding, polishing and assembly create additional sources, while people and materials can introduce particles throughout both environments.
Yes. Reducing airborne particles in surrounding production and support areas helps lower the contamination burden placed on adjacent cleanroom environments and controlled manufacturing spaces.
In pharmaceutical manufacturing, powder handling, blending, milling and tablet compression are major particle sources. In medical device manufacturing, machining, moulding, polishing, laser cutting and assembly can also generate airborne contamination that spreads throughout the facility.
Air quality monitoring provides objective data on where airborne particles are generated, how they move through production areas and which processes create the greatest exposure. This helps prioritise improvement measures based on measurable evidence.
Because contamination control starts before the cleanroom door. People, materials and production processes can introduce or carry particles throughout the wider facility, adding to the contamination burden around controlled environments.
Every pharmaceutical and medical manufacturing environment has its own air quality challenges. I'd be delighted to learn more about your processes, answer your questions and explore how cleaner air can support your contamination control strategy and wider manufacturing environment.
Zehnder Group UK LTD
Clean Air Solutions
Concept House, Watchmoor Point
GU153AD Camberley
United Kingdom
T 0800 0430100
